He added that there are over 4,000 African students in Wuhan, the nation's hardest-hit region, who have bravely and courageously fought the virus with their Chinese colleagues.
He also invited businesses to invest in Pakistan by taking advantage of the government's business-friendly policies.
He also said the US was "capricious", as the two sides had achieved a positive outcome in the agriculture and energy sectors during talks in both Washington in May and in Beijing in early June, but the US has been "acting unpredictably" with its policymaking and holding "big sticks" for negotiations.
He also counted a number of short-term advantages, including clean technologies, infrastructure development, and engineering and logistic services. However, he warned that even the near-term BRI opportunities are clouded by the current trade tensions between the US and China.
He also noted that the DPRK has halted nuclear and missile tests, shut down its nuclear testing site and began dismantling facilities at its rocket launch site.
He also orbited the Moon in Apollo 10 in 1969, and landed there in 1972 as Commander of the Apollo 16 mission.
seo首页排名
He Yanzhe, an expert from China Electronics Standardization Institute, told CCTV that China's Cybersecurity Law stipulates that "lawful, justifiable and necessary" are the three principles that govern the collection and use of personal information, and the sales center using facial recognition clearly violates the three principles. "It is a very typical illegal act and should be dealt with immediately," he said.
He also told reporters that five sites were currently being weighed as the venue for a meeting between him and the DPRK's top leader Kim Jong Un, which has been planned to take place in May or early June.
He added RCEP will not only spell greater synergy for China-ASEAN cooperation but will also ensure that the region continues to be a growth leader in the face of increasing trade protectionism in the West that threatens global prosperity.
He also mentioned that the company has established strategic cooperation with Nanjing Legend Biotech Co, a Chinese biotech startup based in Nanjing, Jiangsu province, hoping to make more breakthroughs in CAR-T therapy, a form of immunotherapy that uses specially altered T cells to fight cancer.